Cargando…

Insight, symptom severity and medication adherence in bipolar disorder

INTRODUCTION: Bipolar disorder is a mood disorder that requires adequate treatment, both acutely and for long-term prevention to avoid recurrence. A growing number of safe and effective medications, particularly thymoregulatory drugs and antipsychotics, can be used for the preventive and long-term t...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelhamid, A., Nokrou, M., Bounouh, S., Belbachir, S., Ouanass, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661448/
http://dx.doi.org/10.1192/j.eurpsy.2023.1448
_version_ 1785137979033911296
author Abdelhamid, A.
Nokrou, M.
Bounouh, S.
Belbachir, S.
Ouanass, A.
author_facet Abdelhamid, A.
Nokrou, M.
Bounouh, S.
Belbachir, S.
Ouanass, A.
author_sort Abdelhamid, A.
collection PubMed
description INTRODUCTION: Bipolar disorder is a mood disorder that requires adequate treatment, both acutely and for long-term prevention to avoid recurrence. A growing number of safe and effective medications, particularly thymoregulatory drugs and antipsychotics, can be used for the preventive and long-term treatment of bipolar disorder. Insight, or awareness of the illness, has been little studied in bipolar disorder. It would seem that the presence of psychotic symptoms and manic polarity are linked to an alteration in clinical insight. The lack of insight could be linked to poor or non-adherence to treatment in psychiatric pathology including bipolar disorder. OBJECTIVES: Our aim is to study the correlation between the level of insight, symptom severity, and medication adherence in patients with bipolar disorder and compare them to those in the literature in order to allow a better therapeutic compliance for patients. METHODS: It is a prospective descriptive study of a series of cases, carried out at the psychiatric hospital Ar-razi in Salé over a period of 4 months. Our inclusion criteria are patients diagnosed with bipolar disorder according to DSM 5 criteria, aged over 18 years. The data are collected during the psychiatric interview with the patient. Insight is assessed by the Beck Cognitive Insight Scale and the severity of the symptoms is assessed by the Clinical Global Impression. RESULTS: Ongoing CONCLUSIONS: Ongoing DISCLOSURE OF INTEREST: None Declared
format Online
Article
Text
id pubmed-10661448
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-106614482023-07-19 Insight, symptom severity and medication adherence in bipolar disorder Abdelhamid, A. Nokrou, M. Bounouh, S. Belbachir, S. Ouanass, A. Eur Psychiatry Abstract INTRODUCTION: Bipolar disorder is a mood disorder that requires adequate treatment, both acutely and for long-term prevention to avoid recurrence. A growing number of safe and effective medications, particularly thymoregulatory drugs and antipsychotics, can be used for the preventive and long-term treatment of bipolar disorder. Insight, or awareness of the illness, has been little studied in bipolar disorder. It would seem that the presence of psychotic symptoms and manic polarity are linked to an alteration in clinical insight. The lack of insight could be linked to poor or non-adherence to treatment in psychiatric pathology including bipolar disorder. OBJECTIVES: Our aim is to study the correlation between the level of insight, symptom severity, and medication adherence in patients with bipolar disorder and compare them to those in the literature in order to allow a better therapeutic compliance for patients. METHODS: It is a prospective descriptive study of a series of cases, carried out at the psychiatric hospital Ar-razi in Salé over a period of 4 months. Our inclusion criteria are patients diagnosed with bipolar disorder according to DSM 5 criteria, aged over 18 years. The data are collected during the psychiatric interview with the patient. Insight is assessed by the Beck Cognitive Insight Scale and the severity of the symptoms is assessed by the Clinical Global Impression. RESULTS: Ongoing CONCLUSIONS: Ongoing DISCLOSURE OF INTEREST: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10661448/ http://dx.doi.org/10.1192/j.eurpsy.2023.1448 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Abdelhamid, A.
Nokrou, M.
Bounouh, S.
Belbachir, S.
Ouanass, A.
Insight, symptom severity and medication adherence in bipolar disorder
title Insight, symptom severity and medication adherence in bipolar disorder
title_full Insight, symptom severity and medication adherence in bipolar disorder
title_fullStr Insight, symptom severity and medication adherence in bipolar disorder
title_full_unstemmed Insight, symptom severity and medication adherence in bipolar disorder
title_short Insight, symptom severity and medication adherence in bipolar disorder
title_sort insight, symptom severity and medication adherence in bipolar disorder
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661448/
http://dx.doi.org/10.1192/j.eurpsy.2023.1448
work_keys_str_mv AT abdelhamida insightsymptomseverityandmedicationadherenceinbipolardisorder
AT nokroum insightsymptomseverityandmedicationadherenceinbipolardisorder
AT bounouhs insightsymptomseverityandmedicationadherenceinbipolardisorder
AT belbachirs insightsymptomseverityandmedicationadherenceinbipolardisorder
AT ouanassa insightsymptomseverityandmedicationadherenceinbipolardisorder